Condition
Acute Ischemic Stroke clinical trials and research
As of November 12, 2026, Find a Trial lists 141 Acute Ischemic Stroke clinical trials that are recruiting, at sites in 41 countries (most in China (87), United States (19), Germany (11)). 4 were first registered in the last 30 days. By phase: Phase 3 (27), Phase 2 (18), Phase 2/3 (5), Phase 4 (5). The most active sponsors are Capital Medical University (7), Xuanwu Hospital, Beijing (6), Tongji Hospital (5). There are also 31 NIH-funded research projects on Acute Ischemic Stroke, with $16.5 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 141Clinical trials
- 31NIH research projects
- 4New in 30 days
- 41Countries
Newest Acute Ischemic Stroke clinical trials
All recruiting trials (141)
-
Short-Term outside-in nerve stimulation for acute ischemic stroke
This trial tests whether a 5-day external trigeminal nerve stimulation given after stroke can help more patients recover better than a sham treatment.
-
Sevoflurane vs. Propofol for anesthesia in stroke patients undergoing clot-removal
This study tests whether sevoflurane or propofol used for anesthesia during endovascular treatment of an acute ischemic stroke affects the final brain damage and recovery.
-
Safety of adding NRICM301 to standard care for adults with acute ischemic stroke
This study tests whether adding NRICM301, a traditional Chinese medicine formula, to usual care is safe for adults with acute ischemic stroke.
-
Intracranial Recanalization with LT3001 in Acute Ischemic Stroke
This phase II study tests whether LT3001 given to adults with acute ischemic stroke can help reopen blocked brain arteries.
-
Mobilisation After Endovascular Stroke Treatment
This study checks whether moving around 12 hours after endovascular stroke treatment is as safe as moving around 24 hours for people with an acute ischemic stroke.
-
Endovascular therapy plus standard care vs standard care alone for distal and medium vessel strokes
In people with acute ischemic stroke due to distal or medium vessel blockages, this study tests whether adding endovascular treatment to the usual medical care helps improve outcomes compared with medical care alone.
-
Acute Ischemic Stroke in People with Active Cancer
This study looks at how often people with active cancer have another ischemic stroke after an initial event, to see what factors might be linked to a recurrence.
-
Anisodine hydrobromide added to standard care for acute ischemic stroke patients undergoing thrombectomy
In people with acute ischemic stroke who are getting endovascular treatment, this study tests whether anisodine hydrobromide plus standard care helps more than standard care plus a placebo.
-
Prourokinase plus standard care vs standard care alone in mid- vessel stroke 4.5–24 hours after onset
This trial tests whether intravenous recombinant human prourokinase can improve outcomes for adults with acute medium vessel occlusion stroke when given 4.5 to 24 hours after onset.
-
FORWARD: Functional Outcomes in Real-World Treatment and Revascularization of Non-dominant and Distal M2 Occlusions
This study tests how the Penumbra System works in real-world patients with non-dominant or distal M2 occlusions who have an acute ischemic stroke, comparing endovascular thrombectomy to medical management alone.
-
Tenecteplase or Reteplase Bridging Before Thrombectomy in Acute Ischemic Stroke
This trial tests whether giving tenecteplase or reteplase before mechanical thrombectomy helps people with acute ischemic stroke due to large vessel occlusion, compared with doing thrombectomy alone.
-
Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute Ischemic Stroke
This study tests whether cerebral autoregulation monitoring during thrombectomy can predict futile recanalization and bad outcomes in adults with acute ischemic stroke.
-
HRS-4029 for Acute Ischemic Stroke: Is It Safe and Helpful
This trial tests whether HRS-4029 given within 3 hours of stroke onset helps people with acute ischemic stroke compared with a placebo.
-
Early Identification of BAD-related Stroke in Adults
This study tests how well a multisource AI diagnostic approach can identify BAD-related stroke among adults with acute ischemic stroke within a week of onset.
-
Early VR-Based Rehab for the Arm After Acute Ischemic Stroke
This trial tests whether starting virtual reality–based arm rehabilitation within 24 hours of an acute ischemic stroke helps improve arm strength, thinking skills, anxiety, and confidence to exercise compared with standard rehab.
-
Endovascular Therapy for Basilar Artery Occlusion With Large Ischemic Core
This trial tests whether adding endovascular therapy to standard medical care helps people with acute basilar artery occlusion and a large area of brain already affected.
-
How well stroke patients move early after a severe stroke using a wearable
This study tests how adults with severe acute ischemic stroke move during their hospital stay by wearing a small activity monitor to see early mobility patterns.
-
Placental-derived 3D mesenchymal stem cells for acute ischemic stroke
A Phase 1/2a trial tests whether a single intravenous dose of human placenta-derived 3D mesenchymal stem cells can be given safely to adults who recently had an ischemic stroke and whether it shows early signs of benefit.
-
BDNF Levels and Cardioembolic Stroke in Ischemic Stroke Patients
This study tests whether blood levels of brain-derived neurotrophic factor (BDNF) relate to cardioembolic stroke risk in people who have had an acute ischemic stroke.
-
TNK for Acute Ischemic Stroke in the Extended Time Window with Simple Imaging
This trial tests whether giving a single IV bolus of tenecteplase helps people with acute ischemic stroke 4.5 to 24 hours after onset, selected using a simple non-contrast CT scan.
-
Real-world use of Medtronic Neurovascular devices for acute ischemic stroke
This registry tests how Medtronic Neurovascular devices perform in everyday treatment of acute ischemic stroke, across multiple centers and patients.
-
Rapid local brain-protecting postconditioning after thrombectomy for acute stroke
This trial tests a quick post-surgery step after clot removal to see if it helps people recover better after a severe stroke caused by a large vessel blockage.
-
Minocycline after successful recanalization in acute anterior circulation stroke
This trial tests whether adding minocycline after a successful endovascular thrombectomy helps people recover better after an acute anterior circulation stroke.
-
Minocycline after successful reopening of posterior circulation stroke with endovascular therapy
This trial tests whether adding minocycline after successful thrombectomy helps people recover better from a posterior circulation stroke.
-
QD202 for acute ischemic stroke patients treated with clot‑busting therapy (no thrombectomy)
This study will test whether giving the drug QD202 by IV infusion after clot‑busting (thrombolysis) helps adults with acute ischemic stroke who are not having a thrombectomy.
-
Ultra-early detection of failed recovery after stroke using cerebral autoregulation during thrombectomy
This study tests whether monitoring how the brain controls blood flow during thrombectomy can quickly show which large-vessel ischemic stroke patients are unlikely to regain function after a successful vessel reopening.
-
Aspiration with a super large bore catheter vs. stent retriever in anterior circulation large vessel occlusion
This trial tests whether using a super large bore catheter for suction works better or worse than using a stent retriever to remove a clot in adults with a major stroke in the front part of the brain.
-
Sivelestat added to endovascular clot retrieval for acute anterior circulation stroke
This study tests whether giving sivelestat sodium alongside mechanical thrombectomy helps improve outcomes for adults with acute ischemic stroke due to large vessel occlusion.
-
Repeated intravenous prourokinase for ischemic stroke with medium to large vessel occlusion within 4.5 hours
This study tests whether giving an extra infusion of prourokinase after initial treatment helps restore blood flow in adults with acute ischemic stroke due to medium or large vessel blockages within 4.5 hours.
-
Early evolocumab plus statin for large-artery ischemic stroke
This will test whether giving evolocumab with a statin soon after a large-artery ischemic stroke helps people recover better than a statin alone.
-
Tenecteplase for late-window stroke guided by DWI-FLAIR mismatch
This study tests whether giving tenecteplase 4.5–9 hours after stroke onset can improve outcomes for patients with MRI showing DWI-FLAIR mismatch.
-
GM1 added to mechanical thrombectomy for large vessel stroke
This trial tests whether giving GM1 after mechanical thrombectomy can help improve recovery for adults with acute anterior circulation large vessel stroke.
-
Tenecteplase after non-contrast CT for unknown-onset stroke
This study tests whether giving tenecteplase helps people with acute ischemic stroke whose onset time is unknown.
-
Intravenous Tenecteplase in Very Old Adults with Acute Ischemic Stroke
This study tests whether giving tenecteplase through a vein within 4.5 hours of stroke onset helps people 80 and older.
-
SUMMIT RISE: Route 92 mechanical reperfusion for acute ischemic stroke
This will test the Route 92 mechanical reperfusion system to see if it helps restore blood flow and improve recovery in adults treated for acute ischemic stroke who received the device as the first pass during thrombectomy.
-
J147 in Acute Ischemic Stroke after Mechanical Thrombectomy
This study tests whether injecting J147 helps people who had an ischemic stroke and underwent clot removal to see if outcomes improve and how safe the drug is.
-
Non-invasive vagus nerve stimulation to lower inflammation and brain injury markers after acute ischemic stroke
This test tries whether adding non-invasive vagus nerve stimulation to usual care lowers inflammation and blood markers of brain injury in adults with acute ischemic stroke from a large vessel occlusion.
-
QHRD106 injection to treat acute ischemic stroke
This study will test whether QHRD106 injections given within 24 hours can help adults with acute ischemic stroke who are not receiving reperfusion therapy.
-
TAK-755 to treat acute ischemic stroke in adults
This will test a single dose of TAK-755 versus placebo to see if it is safe and helps adults who had an acute ischemic stroke within 24 hours.
-
rhPro-UK before endovascular stroke treatment in the extended window
In adults with acute ischemic stroke due to a large vessel blockage, this trial tests whether giving rhPro-UK before thrombectomy in the 4.5–24 hour window helps people recover better than a placebo.
-
Testing B2065 for safety and early effectiveness in acute ischemic stroke
This will test a single IV infusion of B2065 versus placebo in adults 18–75 who have an acute ischemic stroke and can be treated within 36 hours of symptom onset.
-
Tenecteplase to help recovery after an ischemic stroke more than 4.5 hours after last seen well
This trial will test whether a single IV dose of tenecteplase helps adults who had an ischemic stroke (including wake-up strokes) recover when treatment starts more than 4.5 hours after they were last seen well.
-
Endovascular Rescue with Stenting for Large Vessel Occlusion after Partial Clot Removal
This trial tests whether adding a stent to the artery after a mechanical thrombectomy helps patients with large vessel stroke who still have significant narrowing in the artery.
-
Endovascular treatment for acute ischemic stroke caused by M2 segment blockage
This trial will test whether endovascular therapy helps adults (18–84) who have an acute ischemic stroke from a blockage in the M2 segment of the middle cerebral artery.
-
BALANCE: Concurrent thrombolysis for AIS with elevated pre-treatment BP
In people having an acute ischemic stroke with high blood pressure, the BALANCE trial tests whether starting thrombolysis at the same time as BP-lowering treatment is safe and effective enough to consider it instead of waiting for BP to drop first.
-
Remote telemedicine support for acute ischemic stroke care at smaller hospitals
This project will try remote telemedicine support to help adults who arrive within 4.5 hours of an acute ischemic stroke get faster, standardized care at smaller hospitals.
-
Intra-arterial tenecteplase for medium-vessel occlusion stroke
This trial will test whether delivering tenecteplase directly into the blocked medium brain artery helps adults with medium-vessel ischemic stroke recover better when treated within 24 hours of symptom onset.
-
IV thrombolysis for branch atheromatous stroke in deep brain arteries
This study looks at whether intravenous thrombolysis can help people with branch atheromatous disease-related stroke compared with standard antiplatelet therapies.
-
Adding intravenous tirofiban after clot-busting treatment for patients who don't improve quickly from acute ischemic stroke
This trial will test whether giving the IV medicine tirofiban after standard clot-busting treatment helps adults with acute ischemic stroke who show poor improvement within an hour.
-
KPCXM18 injection for acute ischemic stroke.
This trial will try different doses of the KPCXM18 injection to see if it helps adults who have had an acute ischemic stroke when started within 12 hours of symptom onset.
-
Blood pressure management during early clot‑busting treatment for acute ischemic stroke
This trial will test whether an adjusted blood pressure approach is safer than usual care for people with acute ischemic stroke who are receiving IV thrombolysis and have high blood pressure.
-
Albumin plus endovascular therapy for anterior large-vessel ischemic stroke
This trial will try adding albumin to endovascular treatment to see if it helps adults (18–80) with anterior large-vessel ischemic stroke treated within 24 hours.
-
Tenecteplase before transfer for anterior circulation large-vessel stroke (4.5–24 hours)
This will test whether a single bolus of tenecteplase given at the first hospital before transfer helps people with anterior circulation large-vessel ischemic stroke who present 4.5–24 hours after they were last well.
-
SHPL-49 injection for treating acute ischemic stroke (Phase III)
This trial tests whether a seven-day course of intravenous SHPL-49 helps adults with acute ischemic stroke who receive thrombolysis within eight hours of symptom onset.
-
Tenecteplase before transfer for basilar artery stroke 4.5–24 hours after symptom onset
This trial tests whether giving IV tenecteplase before transfer helps people with basilar artery occlusion who are 4.5–24 hours from symptom onset and are being sent for thrombectomy.
-
rhTNK-tPA for large-vessel ischemic stroke treated 4.5–24 hours after last seen normal
This study will try whether a single IV dose of rhTNK-tPA helps adults with large-vessel ischemic stroke who present 4.5 to 24 hours after they were last seen normal, compared with a placebo.
-
CONDA stent retriever for reopening large-vessel blockages in acute ischemic stroke.
The CONDA stent retriever will be tried to reopen blocked large brain arteries in adults with acute ischemic stroke treated within 24 hours of symptom onset.
-
Methylprednisolone given into the artery and IV after thrombectomy for anterior large-vessel stroke
This trial tests whether giving intra-arterial methylprednisolone immediately after a successful thrombectomy followed by three days of IV methylprednisolone helps people with acute anterior large-vessel ischemic stroke recover better.
-
Adding intra-arterial clot-busting therapy to endovascular treatment for medium-vessel stroke
It tests whether adding intra-arterial clot-busting medicine to endovascular treatment helps adults with medium-vessel acute ischemic stroke who can be treated within 24 hours recover better.
-
Thrombectomy plus medical care versus medical care alone for large-vessel ischemic stroke 24–72 hours after last known well
This will see if adding endovascular thrombectomy to usual medical care helps adults with a large-vessel ischemic stroke who arrive 24–72 hours after they were last known to be well.
-
Dual Stentriever Approach in Acute Ischemic Stroke with Large Vessel Occlusion
This study tests whether using two stentrievers together helps people with a large vessel stroke in the front part of the brain.
-
Tenecteplase for Posterior Circulation Stroke Between 4.5 and 24 Hours
This trial tests whether giving tenecteplase through an IV helps people with acute posterior circulation stroke who are between 4.5 and 24 hours from onset.
-
Tenecteplase IV thrombolysis for acute ischemic stroke after recent DOAC use
This will test whether a single IV dose of tenecteplase can improve 90-day recovery in adults who have an acute ischemic stroke and took a direct oral anticoagulant within the past 48 hours.
-
Hyperbaric oxygen after stroke thrombectomy in acute ischemic stroke patients
This trial tests whether giving hyperbaric oxygen after endovascular stroke treatment helps improve outcomes in patients with acute ischemic stroke.
-
Weight-adjusted urokinase dosing for early ischemic stroke
This research will try different weight-based doses of intravenous urokinase given within 6 hours to find a safe, effective dosing plan for adults with acute ischemic stroke.
-
Balloon angioplasty vs stenting after residual intracranial narrowing in acute ischemic stroke
This trial tests whether balloon angioplasty is as good as stenting for patients with residual intracranial narrowing after initial stroke treatment.
-
Endovascular treatment plus tirofiban for strokes from intracranial atherosclerosis
This trial will see if giving tirofiban after endovascular clot removal helps people with acute large-vessel ischemic stroke caused by intracranial atherosclerosis.
-
Tenecteplase for ischemic stroke given after 4.5 hours when CT shows a small infarct
This trial will try whether a single 0.25 mg/kg dose of tenecteplase helps adults with anterior-circulation ischemic stroke who present more than 4.5 hours after last known well and whose non-contrast CT shows limited infarction.
-
Improving outcomes for patients with acute ischemic stroke using JX10
This study is testing if a new treatment called JX10 can help people who have had an acute ischemic stroke feel better and recover more functionally compared to a placebo.
-
Using EEG to Distinguish Between Types of Stroke
This study is testing if brain activity measured by EEG can help doctors tell the difference between two types of strokes and predict how well patients will recover.
-
Biobank for patients with large vessel occlusion stroke
This study is collecting blood and clot samples from patients with large vessel occlusion strokes to see if analyzing them can help improve diagnosis and treatment for these patients.
-
Intra-Arterial Magnesium Therapy After Mechanical Thrombectomy for Acute Ischemic Stroke
This phase I study tests whether injecting magnesium sulfate directly into brain arteries after mechanical clot removal is safe for people with acute ischemic stroke.
-
Comparing 5G Mobile Stroke Units to Standard Emergency Services for Stroke Treatment
This study is testing whether using 5G Mobile Stroke Units can help stroke patients get better treatment compared to regular emergency services.
-
Angong Niuhuang pills with different bovine bezoar sources for acute ischemic stroke
This will try two commercially made Angong Niuhuang pill formulations to see if they help adults with recent acute ischemic stroke recover better and reduce inflammation.
-
Evaluating heart health in patients with acute ischemic stroke receiving reperfusion therapy
This study looks at how heart problems affect people who have had an acute ischemic stroke and are receiving treatment to see if it can help improve their care and outcomes.
-
Using BASIS technique for treating acute large vessel occlusion strokes
This study is testing a new method called BASIS to see if it can safely help people with severe strokes caused by blocked blood vessels in the brain recover better.
-
Thrombolysis for stroke patients on Factor Xa inhibitors
This study is testing if a common stroke treatment can safely help patients who have taken certain blood thinners in the last two days.
-
Qingre Huatan formula to prevent early neurological worsening after acute ischemic stroke
This study will test whether adding the Qingre Huatan herbal formula to standard care can prevent early neurological worsening in adults who have had an acute ischemic stroke within 48 hours of symptom onset.
-
Using platelet aggregation tests to guide antiplatelet treatment in acute ischemic stroke
This trial will test whether switching adults with acute ischemic stroke or high-risk TIA who show clopidogrel resistance on platelet testing to ticagrelor reduces repeat strokes and is safe.
-
AI-guided personalized rehabilitation to improve upper-limb recovery after stroke
This project tests whether an explainable AI system can predict recovery and recommend tailored rehab (usual care alone or plus acupuncture, robotic training, or NMES) for people aged 65–80 who had a first-time unilateral stroke 1–6 months earlier.
-
Remote ischemic conditioning for adults with moderate acute stroke from large artery narrowing
This study will test remote ischemic conditioning plus usual medical care versus usual care alone in adults 18–85 who have a moderate acute ischemic stroke caused by large artery atherosclerosis within 48 hours of symptom onset.
-
Aleeto for moderate to severe acute ischemic stroke
This trial will test whether Aleeto, given within 72 hours of symptom onset, helps improve neurological recovery in adults with moderate to severe acute ischemic stroke compared with placebo.
-
Using intravenous thrombolysis for patients on new oral anticoagulants after a stroke
This study is testing if a common stroke treatment can safely help people who have recently taken new blood thinners after having a stroke.
-
Using MRI to detect bleeding in plaques for stroke diagnosis
This study is trying to see if using MRI to find bleeding in artery plaques can help doctors better diagnose strokes, especially in patients who have unexplained strokes.
-
Brain scans and blood tests to find autonomic (brain–heart) dysfunction after acute ischemic stroke or TIA
This project will test whether MRI scans and blood tests can detect nerve-control problems that affect heart and blood pressure in adults who recently had an ischemic stroke or a transient ischemic attack.
-
Evaluating the Ceretrieve Device for Treating Acute Ischemic Stroke
This study is testing a new device called Ceretrieve to see if it can safely help people with acute ischemic stroke by restoring blood flow to their brains.
-
Using Human Urinary Kallidinogenase to Treat Acute Ischemic Stroke
This study is testing whether a treatment called Human Urinary Kallidin can help reduce inflammation and improve recovery in people who have just had an acute ischemic stroke.
-
Optimizing Blood Pressure Control After Thrombectomy for Stroke
This study tests whether managing blood pressure more tightly after a stroke treatment helps patients recover better and improves their quality of life.
-
Hibernation-like therapy for treating acute ischemic stroke
This study is testing if a combination of two medications can safely help people who have had a stroke during a specific treatment procedure.
-
Evaluating a new catheter for treating severe strokes
This study tests if a new type of catheter can help people with severe strokes recover better than the usual treatment.
-
Extending treatment window for stroke patients with medium vessel occlusions
This study is testing if giving a clot-busting drug to stroke patients with certain types of blockages after the usual treatment time can help them recover better than standard care.
-
Using remote ischemic conditioning to improve outcomes in acute ischemic stroke patients undergoing thrombectomy
This study tests if a new treatment called remote ischemic conditioning can help stroke patients recover better after a procedure to remove a blood clot.
-
Early use of antiplatelet therapy after thrombolysis for stroke
This study tests if giving aspirin right after stroke treatment can help adults feel better and prevent further problems.
-
Assessing treatment strategies for stroke patients with atrial fibrillation
This study is testing different treatment options for stroke patients with atrial fibrillation to see which one helps them recover better and prevents future strokes.
-
Investigating the role of sTREM in outcomes after thrombectomy for stroke
This study is trying to see if certain proteins in the blood can help predict how well people recover after a procedure to remove a blood clot from their brain during a stroke.
-
Collecting real-life data on endovascular treatments for brain aneurysms
This study is collecting real-life information on how safe and effective a specific type of device is for treating brain aneurysms in patients.
-
Evaluating the effects of Calculus Bovis Sativus for ischemic cerebrovascular diseases
This study is testing whether a traditional Chinese medicine called Calculus Bovis Sativus can help improve brain health and reduce inflammation in people with ischemic cerebrovascular diseases like stroke.
-
Evaluating brain metabolism in minor strokes with large vessel occlusion
This study is trying to see how brain metabolism changes in people with minor strokes caused by large blood vessel blockages to help predict their recovery and guide treatment.
-
Weak scalp electrical stimulation to protect the brain after an acute ischemic stroke
This trial will test whether a weak electrical current applied to the scalp can increase collateral blood flow and protect brain tissue in adults with acute ischemic stroke who are not candidates for clot removal.
-
Treatment for Acute Ischemic Stroke Patients with Thrombolysis
This study is testing if a new drug called NoNO-42 can help people aged 45 to 90 who are having an acute ischemic stroke and are getting thrombolysis treatment.
-
Investigating vessel perforation during thrombectomy for stroke treatment
This study looks at complications from thrombectomy procedures for stroke, specifically vessel perforations, to see what causes them and how to improve safety and treatment for patients.
-
Head down tilt to improve blood flow in stroke patients
This study is testing if tilting stroke patients' heads down can improve blood flow to their brains and help them recover better before they receive treatment.
-
Assessing cognitive impairment in young adults after ischemic stroke
This study is testing how an ischemic stroke affects thinking and memory in young adults aged 18-45 over time.
-
Evaluating BB-031 for patients with acute ischemic stroke
This study is testing a new drug called BB-031 to see if it is safe and helpful for people who have had an acute ischemic stroke within the last 24 hours.
-
Combining Human Urinary Kallidinogenase with Endovascular Therapy for Acute Ischemic Stroke
This study is testing if adding a new treatment called Human Urinary Kallidinogenase to standard endovascular therapy can help people who have had a severe stroke caused by a blocked blood vessel.
-
Evaluating treatment options for stroke patients presenting after 24 hours
This study is trying to see if a special procedure or the best medical care can help stroke patients who arrive at the hospital more than 24 hours after their symptoms started.
-
Comparing Urokinase and Alteplase for Treating Acute Ischemic Stroke
This study is testing if a cheaper medication called urokinase works as well and is as safe as the more expensive drug alteplase for treating people with acute ischemic stroke.
-
Comparing regional and general anesthesia for carotid surgery in stroke patients
This study is testing whether regional anesthesia is safer and more effective than general anesthesia for stroke patients undergoing carotid surgery.
-
Using Hyperbaric Oxygen Therapy for Recovery After Acute Ischemic Stroke
This study is testing if Hyperbaric Oxygen Therapy can help people recovering from a stroke improve their movement and daily activities while they are in rehab.
-
Comparing endovascular therapy and best medical treatment for mild acute stroke with large vessel occlusion
This study is testing whether a special treatment for stroke called endovascular therapy can help people with mild strokes caused by a blocked blood vessel feel better compared to just using standard medical care.
-
Using umbilical cord stem cells to treat acute ischemic stroke
This study is testing whether giving umbilical cord stem cells to people who have had an acute ischemic stroke can help them recover better and improve their overall health.
-
Observing treatment options for acute ischemic stroke in Southwest China
This study is tracking 8,000 patients with acute ischemic stroke in Southwest China to see which treatment options work best and how they help people recover over 90 days.
-
Early use of tirofiban after thrombolysis for acute ischemic stroke
This study is testing if giving tirofiban right after a stroke treatment can help patients recover better and stay safe.
-
Testing the RapidPulseTM Aspiration System for treating acute ischemic stroke
This study is testing a new device called the RapidPulseTM Aspiration System to see if it can safely and effectively help people with acute ischemic stroke caused by blocked blood vessels in the brain.
-
Prognostic prediction model for patients with acute stroke undergoing endovascular therapy
This study is trying to create a tool that helps doctors predict how well patients with acute stroke will do after they receive a specific treatment called endovascular therapy.
-
Comparing radial and femoral access for treating acute basilar artery occlusion
This study is testing whether using a wrist (radial) access instead of a groin (femoral) access for treating a specific type of stroke can lead to better results for patients.
-
Registry for Endovascular Treatment of Acute Ischemic Stroke
This study is trying to see how safe and effective a specific treatment for stroke is in helping patients recover after a blocked blood vessel.
-
MRI plus tissue analysis to understand clot-related bleeding and microvascular blockage after large sylvian ischemic stroke treated with hemicraniectomy
This project will test whether special MRI scans combined with small brain tissue samples can better identify clot-related microvessel blockages and bleeding in adults with large sylvian ischemic strokes who need or may need decompressive hemicraniectomy.
-
Prophylactic Stress Ulcer Drugs and Outcomes After Mechanical Thrombectomy in Acute Ischemic Stroke
This observational study looks at whether preventive stress ulcer medicines used after mechanical thrombectomy in adults with acute ischemic stroke affect their outcomes.
-
Evaluating endovascular treatment for acute ischemic stroke caused by carotid artery occlusion
This study is testing if a new treatment combining a special procedure for blocked arteries with standard care can help people who have had a stroke feel better and recover more fully.
-
Registry for patients with acute ischemic stroke caused by large or medium vessel occlusion
This study is creating a registry to track and learn from 50,000 patients with acute ischemic stroke caused by large or medium vessel blockages to see how different treatments work in real life.
-
Evaluating blood pressure variability in acute ischemic stroke patients
This study is testing how changes in blood pressure affect recovery and thinking skills in people who have had an acute ischemic stroke.
-
Sovateltide treatment for acute ischemic stroke
This test will try sovateltide in adults aged 18–80 who had an ischemic stroke within 24 hours to see if it helps improve recovery.
-
Evaluating LT3001 for treating acute ischemic stroke
This study is testing if a new drug called LT3001 can help people who have had an acute ischemic stroke feel better and recover more effectively.
-
Using Semaglutide to reduce damage from acute ischemic stroke
This study is testing if Semaglutide can help reduce brain damage in people who have had an acute ischemic stroke and had no to moderate disability before the stroke.
-
Comparing stenting and non-stenting approaches for acute ischemic stroke treatment
This study is testing whether adding a stent to a common stroke treatment helps people with acute ischemic stroke from a blocked carotid artery recover better than just using the treatment alone.
-
Early use of tirofiban after tenecteplase for acute ischemic stroke
This test sees if giving the antiplatelet drug tirofiban soon after tenecteplase helps adults with acute ischemic stroke avoid reocclusion and improve recovery.
-
Evaluating head acupuncture after thrombectomy for stroke treatment
This study is testing if adding head acupuncture to standard treatment after a stroke helps patients recover better than just the standard treatment alone.
-
Using a standardized treatment system for acute ischemic stroke in Xi'an
This study looks at how a quick treatment system for acute ischemic stroke helps patients in Xi'an recover and what happens to them in the following months.
-
Adding TBO-309 to reperfusion treatment for acute ischemic stroke.
This trial will test whether giving the antiplatelet drug TBO-309 together with clot-dissolving or clot-removal treatment is safe for adults who have just had an acute ischemic stroke.
-
Identifying biomarkers for early detection of acute stroke
This study is trying to find specific markers in blood and saliva that can help doctors quickly and accurately diagnose strokes in adults who come to the emergency room with symptoms.
-
Early rhythm-control therapy for stroke patients with atrial fibrillation
This trial tests whether starting rhythm-control treatment early after an acute ischemic stroke in people with atrial fibrillation can reduce recurrent strokes and other heart-related problems, compared with usual care.
-
Registry of acute ischemic stroke patients at Xuanwu Hospital
This study looks at how well a special fast-track treatment system works for patients with acute ischemic stroke at Xuanwu Hospital in China.
-
Treatment of acute stroke caused by carotid artery issues using a specialized stent
This study is testing a special stent treatment for people who have had a stroke caused by problems in their carotid artery to see if it helps them recover better.
-
Evaluating the safety and usability of BALT medical devices for various brain and vascular conditions
This study is testing how safe and effective BALT medical devices are for treating brain and blood vessel conditions like aneurysms and strokes.
-
Prolonged sedation with dexmedetomidine after stroke treatment
This study tests if using a sedative called dexmedetomidine after stroke treatment can help patients recover better compared to a placebo.
-
Improving treatment for patients with severe strokes
This study is trying to find better ways to treat patients with severe strokes by looking at their brain scans and treatment outcomes to see what works best.
-
Registry for assessing thrombus removal in acute ischemic stroke patients
This study is testing how well the NeVa stent retriever works for removing blood clots in patients who have had a stroke caused by blocked large blood vessels.
-
EmboTrap II clot retriever for re-opening blocked brain arteries in acute ischemic stroke
This registry will see if the EmboTrap II clot retriever can safely and effectively reopen large blocked brain arteries in adults with acute ischemic stroke treated within 12 hours.
-
Registry for endovascular treatment of acute ischemic stroke in Germany
This study is collecting information from patients in Germany who are receiving special procedures for acute ischemic stroke to see how well these treatments work and how safe they are.
-
Registry for blood and tissue samples from stroke patients
This study is collecting blood and tissue samples from stroke patients to see if they can find clues that help understand stroke better and lead to new treatments.
NIH-funded research (31)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Targeted nanomedicine to protect the brain after stroke
A targeted drug-delivery approach aims to boost blood-brain barrier repair and reduce brain damage after an acute ischemic stroke in patients at risk.
-
Modeling Acute Ischemic Stroke to Improve Mechanical Thrombectomy
A research project is creating better computer models and animal studies to help remove clots more safely and effectively in people who have an acute ischemic stroke.
-
Nanoparticle-delivered tPA to overcome clot resistance in acute ischemic stroke
A Mayo Clinic team is testing a nanoparticle-delivered tPA approach to help dissolve clots more effectively in people with acute ischemic stroke due to large vessel blockage.
-
Engineered tissue regulatory T cells as a treatment for stroke
A new off-the-shelf cell therapy using engineered regulatory T cells could help people who have an ischemic stroke recover by reducing inflammation and promoting tissue repair.
-
Fast penumbral imaging to guide stroke treatment
Aims to develop quick MRI techniques to identify tissue at risk in acute ischemic stroke and help decide whether to use advanced clot-busting treatment.
-
Circadian factors shaping reperfusion success in acute stroke
This grant looks at how the body’s internal clock might influence how well stroke patients respond to clot-busting or clot-removal treatments.
-
A practical brain-cooling device to protect the brain during acute ischemic stroke
A new, patient-friendly endovascular cooling system aims to protect brain tissue during emergency stroke treatment to improve recovery.
-
MRI-based brain oxygen use map to guide stroke treatment
A new MRI-based method to measure how much oxygen the brain is using during an acute stroke, to help doctors decide on the best treatment for patients.
-
Benzodiazepine use after stroke in older adults with dementia
This project looks at how benzodiazepines are prescribed to people 65 and older who survived a stroke and have Alzheimer's or related dementias, and whether those prescriptions affect health outcomes.
-
Abbreviated heart MRI to quickly find stroke causes
A short MRI-based test is being developed to quickly and affordably identify the cause of an acute ischemic stroke in patients.
-
Dynamic brain blood vessel changes after a stroke and how they relate to recovery
This project looks at how blood vessels in the brain change after an acute ischemic stroke and whether those changes can help predict a patient’s recovery.
-
Better Brain Oxygen Measurement for Acute Stroke
This project aims to create an easier MRI method to see how much oxygen your brain uses after a stroke, helping doctors make quicker treatment choices.
-
Reducing Brain Damage in Acute Stroke with a New Blood Substitute
This project explores a new blood substitute to help protect brain cells and limit damage after an acute ischemic stroke.
-
Understanding the Connection Between Lungs and Brain After Stroke
This project explores how the lungs and brain communicate after an acute stroke to find new ways to help patients recover.
-
Faster MRI to find salvageable brain tissue after stroke
This project is developing faster MRI scans that spot at-risk but still-salvageable brain tissue for people with acute ischemic stroke so doctors can make quicker treatment decisions.
-
Improving drug delivery to the brain after a stroke using targeted nanomedicine
This study is exploring a new way to deliver medicine directly to the damaged parts of the brain during a stroke, using tiny carriers that can find and target those areas, which could make treatments more effective for people experiencing an acute ischemic stroke.
-
Changes in blood vessel structure after a stroke
This study looks at how blood vessels in the brain change after a stroke and how different treatments can help restore blood flow, with the goal of better understanding recovery and improving care for stroke patients.
-
Investigating how endothelial cell fat metabolism affects outcomes after a stroke
This study is looking at how fat in brain cells affects recovery after a stroke, and it aims to find out if lowering certain fat molecules can help improve healing and movement for people who have had a stroke.
-
Investigating a new treatment for acute ischemic stroke using a specific inhibitor.
This study is looking at how a medication called GSK2256294 might help protect the brain during a stroke by boosting helpful substances that reduce damage and improve blood flow, and it's for both younger and older patients, including those with diabetes and high blood pressure.
-
Mapping oxygen consumption in the brain for stroke evaluation
This study is testing a new MRI method to measure how much oxygen your brain is using after a stroke, which can help doctors understand how much of your brain is still healthy and make better treatment choices for you.
-
Using a new blood substitute to reduce brain damage in stroke patients
This study is looking at a new treatment called Sanguinate® that could help reduce brain damage during a stroke by improving blood flow and oxygen delivery to the affected areas, and it’s designed for people who are having a stroke.
-
New treatment to protect brain cells during a stroke
This study is testing a new treatment that aims to protect brain cells during a stroke, which could help improve recovery and reduce long-term disability for stroke patients.
-
Targeted nanomedicine to protect the brain after an ischemic stroke
This project uses tiny, targeted drug carriers to bring anti-inflammatory medicine directly into damaged brain tissue after an ischemic stroke to limit injury.
-
Understanding how heart conditions contribute to strokes
This study is looking at how certain heart problems might affect recovery after a stroke, and it's for people who have had an acute ischemic stroke to help improve their care and outcomes.
-
Improving recovery from stroke by targeting blood vessel cell metabolism in older mice.
This study is looking at a new way to help older people recover better from a stroke by improving the health of the cells that line their blood vessels, which could boost blood flow and oxygen to the brain.
-
A new way to protect the brain and improve recovery after an ischemic stroke
Developing a treatment to protect brain tissue and help people recover better after a sudden ischemic stroke treated with clot removal.
-
Using advanced MRI to improve treatment for acute ischemic stroke patients
This study is looking at a new way to use special MRI scans to find brain areas that are still healthy enough to treat after a stroke, even if it's been a while since the stroke happened, so that more patients can get the help they need to recover.
-
Monitoring blood flow in the brain during stroke treatment
This study is testing a new, noninvasive way to check blood flow in the brain during and after treatment for strokes, using a special tool that helps doctors catch any problems early and improve care for patients.
-
Improving treatment for acute ischemic stroke using advanced modeling techniques
This study is looking at how blood clots form in the brain and why some can be removed easily while others can't, with the goal of helping doctors improve treatments for people who have had a stroke.
-
New nanomedicine approach for treating acute ischemic stroke
This study is testing a new way to deliver brain-protecting medications directly to the brain for people who have had a stroke, hoping to help them recover better after treatment.
-
New methods to protect the brain and improve recovery after a stroke
This study is looking at new ways to help people recover better after an ischemic stroke by testing a combination of special treatments with current methods, so that patients can have less long-term damage and improve their overall health.
Related topics
Quick answers
How many Acute Ischemic Stroke clinical trials are recruiting right now?
141, as of November 12, 2026. 4 of them were first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 41 countries. The most sites are in China (87 trials), United States (19 trials), Germany (11 trials), Spain (10 trials), France (8 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 27, Phase 2: 18, Phase 2/3: 5, Phase 4: 5. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.